Indian Minister Offers Support To Drug Industry In R&D Expansion
This article was originally published in PharmAsia News
India's union minister for Chemicals and Fertilizers called in a newspaper piece for Indian drug makers to invest more in research and development, and offered the government's support for that effort. Ram Vilas Paswan wrote that his ministry also plans to establish six additional National Institute of Pharmaceutical Education and Research facilities around the country to train the necessary manpower for pharmaceutical companies to expand their R&D efforts. He also said the government would offer its services as a facilitator and catalyst to the industry to meet growing competition at home and abroad. (Click here for more
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
Nuvation started in 2018 and raised a $275m series A round in 2019. Now it is merging with the EcoR1 Capital-sponsored SPAC Panacea Acquisition Corp. and raising $500m in equity capital.